MeiraGTx Holdings plc SEC filings MGTX
MeiraGTx Holdings plc has 509 filings in SEC EDGAR's recent list, going back to Mar 29, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 29, 2023 | — |
| CORRESP | Letter to the SEC | Dec 27, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 4, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2023 | — |
| CT ORDER | Filing | Mar 8, 2022 | — |
| EFFECT | Filing | Jul 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2019 | — |
| CORRESP | Letter to the SEC | Jul 18, 2019 | — |
| EFFECT | Filing | Jul 16, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CERT | Filing | Jun 8, 2018 | — |
| 8-A12B | Filing | Jun 8, 2018 | — |
| CT ORDER | Filing | Jun 8, 2018 | — |
| EFFECT | Filing | Jun 7, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| UPLOAD | Letter from the SEC | May 22, 2018 | — |
| CORRESP | Letter to the SEC | May 21, 2018 | — |
| DRSLTR | Filing | May 11, 2018 | — |
| DRS/A | Filing | May 11, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2018 | — |
| DRS/A | Filing | Apr 13, 2018 | — |
| DRS | Filing | Mar 29, 2018 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MGTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1735438
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.